Invasive Cancer

2

Review clinical trials related to Invasive Cancer. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Advice of Moderate Drinking Pattern Versus Advice on Abstention on Major Disease and Mortality

The goal of this clinical trial is to test two advices on alcohol drinking in more than 10.000 Spanish adult drinkers (men of 50 or more years and women of 55 or more years). The main question it aims to answer is to test the non-inferiority advice of a moderate alcohol drinking pattern on all-cause mortality and other chronic disease like cardiovascular disease, cancer or type 2 diabetes. Participants will receive during 4 years an advice to drink alcohol following a Mediterranean Alcohol Drinking Pattern (MADP): consuming alcohol in moderation, avoidance of binge drinking and preference for red wine. Researchers will compare those who will receive a MADP advice with those who will receive an advice on abstention to see if the advice on MADP is not inferior than the abstention advice to prevent all-cause mortality and other chronic diseases.

Participants needed: 10,000
Trial details
Age: 50-75Biological sex: AllType: InterventionalSponsor: Clinica Universidad de Navarra, Universidad de NavarraUpdated: Dec 12, 2024Locations: 1
Eligibility criteria

Males aged 50-70 years, Women aged 55-75 years [+3]

Participants without smartphone or a computer (or tablet) with Internet connecti... [+6]

Status: Recruiting

A Prospective, Multi-center Clinical Study to Establish Multi-Cancer Early Detection Platform Through the Analysis of Whole Genome Sequencing of Circulating DNA in Cancer Patients and Healthy Volunteers

This is a prospective, multi-center clinical study of Multi-Cancer Early Detection (MCED) testing in cancer patients and healthy volunteers. The purpose of this study is to establish MCED platform through the analysis of whole genome sequencing of circulating DNA. The study will enroll 4,000 subjects as defined by eligibility criteria at up to 10 clinical institutions in South Korea.

Participants needed: 4,000
Trial details
Age: 19+Biological sex: AllType: ObservationalSponsor: Yonsei UniversityUpdated: Jan 30, 2024Locations: 1
Eligibility criteria

Aged 19 years or older [+4]

Subjects who are not appropriate for the study because of intellectual disabilit... [+3]